青鹏软膏对皮肤干燥志愿者及特应性皮炎样小鼠模型皮肤屏障功能的影响

摘要/Abstract

摘要：

目的探讨青鹏软膏对皮肤屏障功能的影响及其可能机制。方法招募12名小腿伸侧皮肤干燥的女性志愿者，青鹏软膏涂于右小腿伸侧（青鹏侧）、青鹏软膏基质涂于左小腿伸侧（基质侧），用药7 d。分别于用药前、用药3 d及用药7 d测定皮肤屏障功能相关指标，如，经表皮失水量（TEWL）及角质层含水量。2,4-二硝基氟苯诱导小鼠背部产生特应性皮炎样改变，分别外用青鹏软膏基质（基质组），50%、75%、100%青鹏软膏治疗（50%、75%、100%青鹏组），每天2次，用药2周后，进行组织病理检查，背部皮褶厚度、TEWL的测定，免疫组化测定表皮丝聚蛋白，外皮蛋白及激肽释放酶7含量。结果志愿者外用青鹏软膏及其基质，3 d、7 d后均较治疗前TEWL显著下降（青鹏侧t = 2.651、3.615；基质侧t = 2.996、3.586，均P < 0.05），含水量显著上升（青鹏侧t = 9.029、13.842；基质侧t = 5.830、11.299，均P < 0.001）。青鹏侧及基质侧TEWL、含水量比较，差异无统计学意义（P > 0.05）。从外观、皮褶厚度及组织病理看，基质组小鼠与模型组相比，皮炎程度差异不大，各青鹏组小鼠皮炎均有不同程度缓解。基质组、青鹏组TEWL均较模型组下降（P < 0.05），而基质组与青鹏组TEWL比较，差异无统计学意义（P > 0.05）。基质组、青鹏组KLK7表达均较模型组下降（P < 0.05），但各治疗组间比较，差异无统计学意义（P > 0.05）。结论青鹏软膏基质有改善皮肤屏障功能的作用。

Abstract:

Li Yunzhu, Lu Xueyan, Jiang Wei, Li Linfeng Department of Dermatology, Beijing Children′s Hospital, Capital Medical University, Beijing 100045, China （Li YZ）; Department of Dermatology, Peking University Third Hospital, Beijing 100191, China （Lu XY, Jiang W）; Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China （Li LF） Corresponding author: Li Linfeng, Email: zoonli@sina.com 【Abstract】 Objective To estimate effects of Qingpeng ointment on skin barrier function, and to explore their potential mechanisms. Methods A total of 12 female volunteers with xerosis on the extensor surfaces of legs were enrolled into this study. All the volunteers were topically treated with Qingpeng ointment on the right leg （Qingpeng side） and its vehicle on the left leg （vehicle side） twice daily for 7 consecutive days. Skin barrier function-associated indexes including transepidermal water loss （TEWL） and the water content of the stratum corneum were measured before the treatment, after 3- and 7-day treatment separately. Thirty-six BALB/c female mice were randomly and equally divided into 6 groups: a blank control group receiving no induction or treatment, a model group induced by 2, 4-dinitrofluorobenzene （DNFB） on the back for 5 consecutive weeks, 3 Qingpeng groups and a vehicle group induced by DNFB on the back for 5 consecutive weeks followed by topical treatment with different concentrations （50%, 75%, 100%） of Qingpeng ointment or its vehicle twice a day for 2 consecutive weeks. At the end of treatment, skin appearance of mice was observed with naked eyes, skinfold thickness and TEWL were measured. Then, all the mice were sacrificed, and skin tissue specimens were resected from the back of mice followed by histopathologic examination and immunohistochemical staining for the detection of filaggrin （FLG）, involucrin （IVL） and kallikrein 7 （KLK7） expressions in the epidermis. Results After start of treatment, both the Qingpeng side and vehicle side showed significantly decreased TEWL on day 3 （t = 2.651, 2.996, respectively, both P < 0.05） and 7 （t = 3.615, 3.586, respectively, both P < 0.05）, but increased water content of the stratum corneum on day 3 （t = 9.029, 5.830, respectively, both P < 0.001） and 7 （t = 13.842, 11.299, respectively, both P < 0.001） compared with those before the treatment. However, no significant differences were observed in TEWL or the water content of the stratum corneum between the Qingpeng side and vehicle side at any of the time points （all P > 0.05）. In addition, there were no marked differences in mouse skin appearance, skinfold thickness or histopathologic manifestations between the vehicle group and model group, while the manifestations of dermatitis were attenuated to different extents in the three Qingpeng groups compared with the model group. Both TEWL and KLK7 expression levels were significantly decreased in the vehicle group and three Qingpeng groups compared with the model group （all P < 0.05）, but similar between the vehicle and Qingpeng groups （all P > 0.05）. Conclusion The vehicle of Qingpeng ointment can improve skin barrier function.

李云珠路雪艳李邻峰. 青鹏软膏对皮肤干燥志愿者及特应性皮炎样小鼠模型皮肤屏障功能的影响[J]. 中华皮肤科杂志, 2016, 49(1): 43-47.doi:

LU XueYan. Effects of Qingpeng ointment on skin barrier function in volunteers with xerosis and atopic dermatitis-like mouse models[J]. Chinese Journal of Dermatology, 2016, 49(1): 43-47.doi:

参考文献 14

［1］	中国中西医结合学会皮肤性病专业委员会环境与职业性皮肤病学组. 外用中成药治疗湿疹皮炎的专家共识（2014）［J］. 中华皮肤科杂志, 2014, 47（6）: 440⁃441. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.06.023.
	Environmental and Occupational Skin Disease Group, Committee on Dermatology and Venereology, China Society of Integrated Traditional Chinese and Western Medicine. Topical treatment of eczema and dermatitis with traditional Chinese medicines: an expert consensus statement［J］. Chin J Dermatol, 2014, 47（6）: 440⁃441. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.06.023.
［2］	李园园, 李邻峰. 青鹏软膏对小鼠特应性皮炎模型的影响及机制研究［J］. 中华皮肤科杂志, 2013, 46（1）: 24⁃27. DOI: 10.3760/cma.j.issn.0412⁃4030.2013.01.009.
	Li YY, Li LF. Effect of Qingpeng ointment on experimental atopic dermatitis in mice and its possible mechanisms［J］. Chin J Dermatol, 2013, 46（1）: 24⁃27. DOI: 10.3760/cma.j.issn.0412⁃4030. 2013.01.009.
［3］	李园园, 李邻峰. 青鹏软膏对小鼠实验性刺激性接触性皮炎的抑制作用及可能机制研究［J］. 中华皮肤科杂志, 2012, 45（9）: 650⁃654. DOI: 10.3760/cma.j.issn.0412⁃4030.2012.09.013.
	Li YY, Li LF. Inhibitory effect of Qingpeng ointment on experimental irritant contact dermatitis in mice and its possible mechanisms［J］. Chin J Dermatol, 2012, 45（9）: 650⁃654. DOI: 10.3760/cma.j.issn.0412⁃4030.2012.09.013.
［4］	路雪艳, 李云珠, 门月华, 等. 特应性皮炎样小鼠模型皮肤屏障功能受损的分子机制研究［J］. 中国麻风皮肤病杂志, 2013, 29（3）: 164⁃167. DOI: 10.3969/j.issn.1009⁃1157.2013.03.006.
	Lu XY, Li YZ, Men YH, et al. Study on molecular mechanisms of impaired skin barrier function in an atopic dermatitis⁃like animal model［J］. Chin J Lepr Skin Dis, 2013, 29（3）: 164⁃167. DOI: 10.3969/j.issn.1009⁃1157.2013.03.006.
［5］	Li YZ, Lu XY, Jiang W, et al. Anti⁃inflammatory effect of qingpeng ointment in atopic dermatitis⁃like murine model［J］.Evid Based Complement Alternat Med, 2013, 2013: 907016. DOI: 10.1155/2013/907016.
［6］	Kim BE, Leung DY. Epidermal barrier in atopic dermatitis［J］. Allergy Asthma Immunol, Res, 2012, 4（1）: 12⁃16. DOI: 10.4168/aair.2012.4.1.12.
［7］	Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier［J］. Exp Dermatol, 2008, 17（12）: 1063⁃1072.
［8］	Weidinger S, Baurecht H, Wagenpfeil S, et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 （SPINK5）, kallikrein⁃related peptidase 7 （KLK7）, and filaggrin （FLG） polymorphisms to eczema risk［J］. J Allergy Clin Immunol, 2008, 122（3）: 560⁃568. DOI: 10.1016/j.jaci.2008.05.050.
［9］	Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis［J］. J Invest Dermatol, 2009, 129（8）: 1892⁃1908. DOI: 10.1038/jid.2009.133.
［10］	Kim BE, Leung DY, Boguniewicz M, et al. Loricrin and involucrin is down⁃regulated by Th2 cytokines through STAT⁃6［J］. Clin Immunol, 2008, 126（3）: 332⁃337. DOI: 10.1016/j.clim.2007.11.006.
［11］	Komatsu N, Saijoh K, Kuk C, et al. Human tissue kallikrein in the stratum corneum and serum of atopic dermatitis patients［J］. Exp Dermatol, 2007, 16（6）: 513⁃519. DOI: 10.1111/j.1600⁃0625.2007.00562.x.
［12］	Sevilla LM, Nachat R, Groot KR, et al. Mice deficient in involucrin, envoplakin, and periplakin have a defective epidermal barrier［J］. J Cell Biol, 2007, 179 （7）: 1599⁃1612. DOI: 10.1083/jcb.200706187.
［13］	Hansson L, Bäckman A, Ny A, et al. Epidermal over of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis［J］. J Invest Dermatol, 2002, 118（3）: 444⁃449. DOI: 10.1046/j.0022⁃202x.2001.01684.x.
［14］	Buraczewska I, Berne B, Lindberg M, et al. Long⁃term treatment with moisturizers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation［J］. Arch Dermatol Res, 2009, 301（2）: 175⁃181. DOI: 10.1007/s00403⁃008-0906⁃6.